Abstract
It is largely recognized that PDCD4 is frequently lost in tumors of various origins, including lung cancer, and its loss contributes to tumor progression. However, its role and molecular mechanism remain largely unexplored in non-small cell lung cancer (NSCLC). In this study, downregulated PDCD4 mRNA expression was found in NSCLC tissues compared to their corresponding paracarcinoma tissues and distal paracarcinoma tissues. Induced expression of PDCD4 inhibited cell growth and proliferation and cell cycle transition in vitro. Conversely, knocking down PDCD4 expression promoted cell growth and proliferation. Mechanistically, PDCD4 inactivated PI3K/Akt signaling and its downstream cell cycle factors CCND1 and CDK4 to regulate cell growth in NSCLC. Additionally, PI3K-specific inhibitor Ly294002 suppressed the expression of pPI3K (Tyr458), pAkt (Ser473), CCND1, and CDK4 in PC9-shPDCD4 and A549-shPDCD4 cells. Furthermore, Akt-specific inhibitor MK2206 inhibited the expression of pAkt (Ser473), CCND1, and CDK4 in PC9-shPDCD4 and A549-shPDCD4 cells. Taken together, our study provides evidence that PDCD4 inhibits cell growth through PI3K/Akt signaling in NSCLC and may be a potential therapeutic target for NSCLC.
References
May 1, 1993·Genes & Development·V BaldinG Draetta
Feb 16, 2002·Methods : a Companion to Methods in Enzymology·K J Livak, T D Schmittgen
Sep 11, 2002·Biochemical and Biophysical Research Communications·Alexandra GökeYouhai H Chen
Aug 2, 2003·Oncogene·Maret BöhmKarl-Heinz Klempnauer
Aug 5, 2003·The Journal of Pathology·Yuan ChenIver Petersen
Nov 25, 2003·Biology of the Cell·Brigitte Lankat-Buttgereit, Rüdiger Göke
Aug 31, 2004·Oncogene·Nadja BitomskyKarl-Heinz Klempnauer
Jul 19, 2005·Cancer Research·Aaron P JansenNancy H Colburn
May 10, 2006·Oncogene·H ZhangS Matsuhashi
Oct 21, 2006·Science·N Valerio DorrelloMichele Pagano
Sep 11, 2007·Oncogene·Q WangH-S Yang
Sep 13, 2007·Cancer·Giridhar MudduluruHeike Allgayer
Jan 29, 2008·The Journal of Biological Chemistry·Nathalie CarayolLeonidas C Platanias
Apr 23, 2008·Oncogene·N BitomskyK-H Klempnauer
May 7, 2008·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Svetlana V KalinichenkoIgor V Korobko
Jul 14, 2009·The Journal of Pathology·Raffaele BaffaAnne Rosenberg
Apr 12, 2011·Journal of Translational Medicine·Aibing WuZhixiong Yang
Mar 7, 2012·Genes & Cancer·Xiaoling GuoHsin-Sheng Yang
Aug 3, 2013·Cell Death & Disease·L HuangM Zheng
Oct 26, 2013·Cell Death & Disease·Yan ZhenWeiyi Fang
Jan 9, 2014·CA: a Cancer Journal for Clinicians·Rebecca SiegelAhmedin Jemal
Apr 12, 2014·Cell Death & Disease·H WangX Lv
Citations
Oct 21, 2017·Cancer Biology & Therapy·Lei LiXin-Yuan Guan
Jun 19, 2018·Biology of Reproduction·Yue LiZengtao Wei
Sep 28, 2018·Cancer Biology & Therapy·Rajpal S BurmiHarpreet S Wasan
Sep 17, 2016·Oncotarget·Kai YinWenxian Guan
Oct 20, 2018·Oncology Letters·Nannan GuoJianqi Yu
Aug 20, 2019·Oncology Letters·Daqing WangAnhua Wang
Sep 24, 2019·Artificial Cells, Nanomedicine, and Biotechnology·Gaiping WangCuifang Chang
Sep 27, 2018·Molecular Cancer Therapeutics·Joel D MaustJudith S Sebolt-Leopold
Feb 1, 2018·Anti-cancer Drugs·Jinkun LiuHongbing Cai
Nov 3, 2020·Cancer Biology & Therapy·Quantang PangHongyu Lu
Nov 21, 2019·Current Molecular Medicine·Wenhui WangJinming Li
Aug 5, 2020·RNA·Andrés Di PaoloJosé R Sotelo-Silveira
Aug 2, 2018·International Journal of Oncology·Pin GuoLijuan Zhang
Jun 6, 2021·Stem Cells and Development·Yang JiangChengyun Zheng